Product Description
| Cat Number | AV-020 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Endogenous HIV-1 inhibitor |
| Modification | None |
| Purity | >95% by hplc |
| Biomarker Target | Antivirals |
| Sequence Three Letter Code | H-Leu-Glu-Ala-Ile-Pro-Met-Ser-Ile-Pro-Pro-Glu-Val-Lys-Phe-Asn-Lys-Pro-Phe-Val-Phe-OH |
| Molecular Formula | C112H171N23O27S |
| Sl Sequence | LEAIPMSIPPEVKFNKPFVF |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Münch et al (2007)Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell 129(2) 263 PMID: 17448989Müller et al (2018) Reduced Susceptibility to VIRIP-Based HIV-1 Entry Inhibitors Has a High Genetic Barrier and Severe Fitness Costs. J Virol. 92(17) e00733-18 PMID: 29925662 Related areasAll peptides >All antiviral agents > |
| Note | The product is for research use only |
Share Item: